| NCT06663605 | Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. | COMPLETED | PHASE1 | 2024-11-05 | 2025-08-07 | 2025-07-07 |
| NCT05470387 | A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection | TERMINATED | PHASE3 | 2022-06-28 | 2023-08-11 | 2023-03-06 |
| NCT04390217 | LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia | WITHDRAWN | PHASE2 | 2021-10-31 | 2022-03-31 | 2021-12-31 |
| NCT02836470 | A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection | COMPLETED | PHASE2 | 2019-10-01 | 2023-09-08 | 2023-09-06 |
| NCT02317549 | Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 | TERMINATED | PHASE2 | 2015-04 | 2016-03 | 2016-03 |